NovAliX
BioParc
850 bld Sebastien
Brant
Illkirch
67400
France
Tel: 33-0-368-330-200
Fax: 33-0-368-330-201
Website: http://www.novalix-pharma.com/
Email: info@novalix-pharma.com
About NovAliX
NovAliX is a private company, owned by its executive management, scientific founders and employees; located in Illkirch near Strasbourg.Based upon the initial concept of transferring academic knowledge into valuable industrial applications; NovAliX has become a trusted provider of expert services to clients ranging from virtual companies to the global players. NovAliX provides a valuable extension to any in-house capabilities ensuring that managers, scientists and project leaders meet or exceed their targeted objectives.
LEADERSHIP:
CSO: Luc Van Hijfte
JOBS:
Please click here for NovAliX job opportunities.
15 articles about NovAliX
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
NovAliX Signs Insourcing Agreement With UCB Biopharma
3/7/2017
-
NovAliX Turns To High-Resolution Cryo-Transmission Electron Microscopy For Pre-Clinical Drug Discovery Research
3/1/2017
-
FEI Company And NovAliX Partner To Provide Electron Microscopy-Based Structural Biology Services For The Pharmaceutical Industry
3/21/2016
-
The NovAliX/Kyowa Hakko Kirin Alliance Will Commence A Fragment-Based Drug Discovery Project Targeting An Important Protein/Protein Interaction
11/18/2013
-
NovAliX and Inventiva Form a Strategic Alliance on Nuclear Receptors
4/9/2013
-
NovAliX Enters Into Fragment-Based Drug Discovery Alliance With Kyowa Hakko Kirin
1/14/2013
-
NovAliX Names Dr. Luc Van Hijfte as CSO Drug Discovery
10/17/2012
-
NovAliX and Servier Collaborate in Early Discovery Research Program
10/9/2012
-
NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma
1/12/2012
-
NovAliX to Collaborate With the Fondation Jerome Lejeune on Down Syndrome (Trisomy 21)
9/13/2011
-
NovAliX and Galapagos NV Collaborate in Osteoarthritis Discovery Research Program
8/29/2011
-
NovAliX Signs Multiyear Services Agreement for Chemistry
2/28/2011
-
NovAliX Acquires a Majority Interest in Graffinity Pharmaceuticals GmbH
11/16/2010
-
Novalyst Discovery and AliX Agree to Merge to Launch NovAliX
9/30/2008